Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropathischer Pruritus.
Pereira MP, Metz M. Pereira MP, et al. Among authors: metz m. Dermatologie (Heidelb). 2024 Sep;75(9):728. doi: 10.1007/s00105-024-05390-z. Dermatologie (Heidelb). 2024. PMID: 38922441 German. No abstract available.
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists.
Wollam J, Solomon M, Villescaz C, Lanier M, Evans S, Bacon C, Freeman D, Vasquez A, Vest A, Napora J, Charlot B, Cavarlez C, Kim A, Dvorak L, Selfridge B, Huang L, Nevarez A, Dedman H, Brooks J, Frischbutter S, Metz M, Serhan N, Gaudenzio N, Timony G, Martinborough E, Boehm MF, Viswanath V. Wollam J, et al. Among authors: metz m. J Allergy Clin Immunol. 2024 Oct;154(4):1033-1043. doi: 10.1016/j.jaci.2024.07.002. Epub 2024 Jul 5. J Allergy Clin Immunol. 2024. PMID: 38971540 Free article.
The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease Control.
Siebenhaar F, Sofi S, Neisinger S, Akin C, Pyatilova P, Grekowitz E, Haendel A, Hawro T, Kiefer L, Magerl M, Metz M, Maurer M, Weller K. Siebenhaar F, et al. Among authors: metz m. J Allergy Clin Immunol Pract. 2024 Dec 4:S2213-2198(24)01237-6. doi: 10.1016/j.jaip.2024.11.021. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39637940 Free article.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. Among authors: metz m. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
A Learnable Prior Improves Inverse Tumor Growth Modeling.
Weidner J, Ezhov I, Balcerak M, Metz MC, Litvinov S, Kaltenbach S, Feiner L, Lux L, Kofler F, Lipkova J, Latz J, Rueckert D, Menze B, Wiestler B. Weidner J, et al. Among authors: metz mc. IEEE Trans Med Imaging. 2024 Nov 8;PP. doi: 10.1109/TMI.2024.3494022. Online ahead of print. IEEE Trans Med Imaging. 2024. PMID: 39514352
734 results